The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback